Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

148.18 -3.92 (-2.58%)
Official Closing Price Updated: 4:15 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,819,359
Open 153.31
Bid (Size) 148.40 (2)
Ask (Size) 148.85 (2)
Prev. Close 152.10
Today's Range 148.07 - 153.68
52wk Range 115.03 - 217.25
Shares Outstanding 385,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Check Out What Whales Are Doing With MRNA
 
Via Benzinga
China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine
Chinese health authorities approved CSPC Pharmaceuticals Group Ltd's (OTC: CSPCY) messenger RNA (mRNA) COVID-19 vaccine for emergency use authorization. 
Via Benzinga

Performance

YTD
-17.21%
-17.21%
1 Month
-7.44%
-7.44%
3 Month
-26.34%
-26.34%
6 Month
+14.24%
+14.24%
1 Year
-15.51%
-15.51%

More News

Read More
Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks
Via Benzinga
If You Invested $5,000 in Moderna in 2020, This Is How Much You Would Have Today
Via The Motley Fool
Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders
Via Investor's Business Daily
Moderna Wants $130 Per COVID-19 Vaccine Dose, US Health Authorities Warn Of Incurable Deadly Fungal Infection, Elon Musk Wants Interest Rate Cut: Today's Top Stories
Via Benzinga
This Is What Whales Are Betting On Moderna
Via Benzinga
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
Via Benzinga
Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose
Via Benzinga
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Via Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via News Direct
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via TheNewswire.com
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via Benzinga
2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market
Via The Motley Fool
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
Via Benzinga
12-Stock Portfolio -- 25 Growth Stocks to Buy Now
Via The Motley Fool
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
Via The Motley Fool
Is It Time to Buy the S&P 500's 2 Worst-Performing February Stocks?
Via The Motley Fool
This High-Growth Company Is Expanding. Time to Buy the Stock?
Via The Motley Fool
ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies
Via InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
Via The Motley Fool
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
Via InvestorPlace
Moderna Announces Phase 2 Data on mRNA-4157/V940, an Investigational mRNA Personalized Cancer Vaccine, to be Presented at the 2023 AACR Annual Meeting
Via ACCESSWIRE
My Hedge Against The Silicon Valley Bank Crisis
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.